|
Gene Vaccines5 H5 _2 P- a0 P* i
Thalhamer, Josef; Weiss, Richard; Scheiblhofer, Sandra (Eds.)6 y) \, k8 ^3 C" \, f8 k
1st Edition., 2012, XI, 330 p. 49 illus., 41 in color.+ c& s3 Y6 Z7 N d* b" E* j
5 E. m! m" ?# f1 s3 E1 ]& a6 C# D$ K
Hardcover, ISBN 978-3-7091-0438-5: V- G/ t7 l! k, Z
Online orders shipping within 2-3 days/ L9 _. _- t& M( D, b: y+ U% @
149,95 : O: Q& M( ?. p- p" O! m
6 B8 N4 Y3 ^# t; Q8 p目录
# _( e" a9 { JPreface.- 1 General mechanisms of gene vaccines.- 2 Strategies to Improve DNA Vaccine Potency: HPV-associated Cervical Cancer as a Model System.- 3 Immune-activating mechanisms of replicase-based DNA and RNA vaccines and their role in immune-apoptosis.- 4 Cytokine genes as molecular adjuvants for DNA vaccines.- 5 Pharmaceutical non-viral formulations for gene vaccines.- 6 Rational design of formulated DNA vaccines: the DermaVir approach.- 7 In vivo electroporation.- 8 Electroporation-based Trigrid™ delivery system (TDS) for DNA vaccine administration.- 9 Prime Boost Regimens for Enhancing Immunity: Magnitude, Quality of Mucosal and Systemic Gene Vaccines.- 10 Intranodal genetic immunization.- 11 Immunotherapy of cancer with RNA vaccines.- 12 DNA and RNA vaccines for prophylactic and therapeutic treatment of type I allergy.- 13 Approved veterinary vaccines – paving the way to products for human use.- 14 Current status of regulations for DNA vaccines.- 15 State of the art production of antibiotic resistance-free plasmid DNA.- 16 Industrial Manufacturing of Plasmid-DNA Products for Gene Vaccination and Therapy./ @, Y, I0 v: E, w
+ |" ^/ w( z3 a U下载地址:7 M& }; t5 J. B8 I
, z+ N j! Z& n+ f
$ O, A% A+ `! X e% h
|
|